• December 15, 2020

    First Patient Dosed in Emalex Biosciences Phase 2 Clinical Trial for Stuttering

    Chicago – December 15, 2020 – Emalex Biosciences, [...]

  • September 9, 2020

    Jon DeVries Named Qlarity Imaging Chief Executive Officer

    Chicago, September 9, 2020 – Life science innovator [...]

  • September 1, 2020

    Emalex Biosciences Phase 2b Tourette Syndrome Clinical Trial Reaches Enrollment Milestone

    – Half of participants are now enrolled in [...]

  • August 21, 2020

    Harmony Biosciences Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

    PLYMOUTH MEETING, PA and CHICAGO, IL, August 21, [...]

  • August 19, 2020

    Harmony Biosciences Announces Pricing Of Upsized Initial Public Offering

    PLYMOUTH MEETING, PA and CHICAGO, IL, August 18, [...]

  • August 12, 2020

    Paragon Biosciences Appoints Kerensa Jimenez as Paragon Health Capital Chief Executive Officer

    Chicago, August 12, 2020 – With strong momentum [...]

  • August 6, 2020

    Sterling Bay Signs Lease with Evozyne, LLC at Lincoln Park Life Science Building, 2430 N Halsted

    Sterling Bay Signs Lease with Evozyne, LLC at [...]

  • July 23, 2020

    Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology

    Publication in peer-reviewed journal Science demonstrates the foundation [...]